TABLE 2.
Group | Case N. | Semen volume (ml) | Sperm concentration (millions/ml) | TSN (millions/ejaculate) | IM (millions/ml) | NP (millions/ml) | PR (millions/ml) | PR (%) | Total PR (millions) |
A | #66 | 3.7 | 49.0 | 181.3 | 18.0 | 1.0 | 30.0 | 61% | 111.0 |
#76 | 3.0 | 92.0 | 276.0 | 30.0 | 10.0 | 52.0 | 57% | 156.0 | |
#97 | 3.2 | 75.0 | 240.0 | 32.0 | 1.0 | 42.0 | 56% | 134.4 | |
#07 | 3.0 | 81.0 | 243.0 | 25.0 | 2.0 | 54.0 | 67% | 162.0 | |
#09 | 2.2 | 135.0 | 297.0 | 70.0 | 10.0 | 55.0 | 41% | 121.0 | |
#24 | 3.9 | 68.0 | 265.2 | 32.0 | 0 | 36.0 | 53% | 140.4 | |
#53 | 3.7 | 87.0 | 321.9 | 15.0 | 2.0 | 70.0 | 80% | 259.0 | |
#61 | 2.9 | 66.0 | 197.2 | 15.0 | 3.0 | 50.0 | 74% | 145.0 | |
#63 | 2.5 | 140.0 | 350.0 | 65.0 | 0.0 | 75.0 | 54% | 187.5 | |
B | #70 | 1.9 | 7.6 | 14.4 | 3.7 | 0.4 | 3.5 | 46% | 6.65 |
#72 | 2.2 | 0.8 | 1.8 | 0.5 | 0 | 0.3 | 38% | 0.66 | |
#74 | 1.3 | 22.0 | 28.6 | 12.0 | 0.8 | 9.2 | 42% | 11.96 | |
#77 | 3.4 | 0.006 | 0.02 | 0.004 | 0.0004 | 0.0012 | 21% | 0.004 | |
#42 | 2.2 | 0.026 | 0.06 | 0.02 | 0 | 0.006 | 23% | 0.013 | |
#83 | 1.5 | 15.0 | 22.5 | 6.0 | 1.0 | 8.0 | 53% | 12.0 | |
#84 | 4.0 | 3.8 | 15.2 | 3.5 | 0.2 | 0.1 | 3% | 0.40 | |
#86 | 1.1 | 26.3 | 28.9 | 25.0 | 0.3 | 1.0 | 4% | 1.10 | |
#88 | 3.0 | 6.3 | 18.9 | 4.0 | 2.0 | 0.3 | 5% | 0.90 | |
#89 | 3.0 | 18.0 | 54.0 | 14.0 | 0.5 | 3.5 | 19% | 10.50 | |
#93 | 1.7 | 11.2 | 19.0 | 2.9 | 0.5 | 7.8 | 70% | 13.26 |
Semen were evaluated according to World Health Organization [WHO] (2010) with Makler chamber. TSN, total sperm number; IM, immotile sperm cells; NP, non-progressive motile sperm cells; PR, progressive motile sperm cells; Total PR, total progressive motile sperm cells.